Cdt1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdt1 Antibodies for research in cell cycle regulation and DNA replication. Cdt1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdt1, or Chromatin Licensing and DNA Replication Factor 1, plays a crucial role in the initiation of DNA replication by ensuring that DNA is replicated only once per cell cycle. Regulation of Cdt1 is vital for maintaining genomic stability, and its dysregulation has been implicated in various cancers. Understanding Cdt1 function and regulation advances knowledge of cell proliferation and tumorigenesis. Researchers can explore Cdt1's role in DNA replication licensing and cell cycle control through multiple experimental approaches. Current investigations focus on how Cdt1 interacts with other replication factors and checkpoint proteins. Ongoing studies examine Cdt1's involvement in cancer development and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies for Cdt1 support researchers worldwide in advancing scientific understanding of cell cycle regulation and cancer biology.